Ace Report Cover
AAOS2018: Additional liposomal bupivacaine infiltration to ISBPB of no benefit in TSA
Reprints
Cite This
Reprints
Cite This
AceReport Image
Shoulder & Elbow
AAOS2018: Additional liposomal bupivacaine infiltration to ISBPB of no benefit in TSA

75 patients scheduled for total shoulder arthroplasty under an interscalene brachial plexus block were randomized to either receive or not receive additional intraoperative infiltration of liposomal bupivacaine within the periarticular soft tissues. Patients were assessed for narcotic consumption over the first 24 hours after surgery, and pain scores over the first 72 hours postoperatively. Results on total morphine equivalents in the first 24 hours demonstrated significantly higher consumption among patients administered the periarticular liposomal bupivacaine infiltration compared to those who were not. Pain scores did not significantly differ between groups at any time point up to 72 hours postoperatively.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. AAOS2018: Additional liposomal bupivacaine infiltration to ISBPB of no benefit in TSA. ACE Report. 2018;8(3):30. Available from: https://myorthoevidence.com/AceReport/Report/

Copy Citation
Share this Ace Report